Nonetheless, these limitations do not diminish the relevance of this study, which provides novel insights into the potential of CRISPR/Cas9-mediated MMP-9 silencing as a promising strategy to impair bladder cancer cell migration and invasion in vitro, paving the way for future mechanistic and preclinical investigations. The gene discussed is MMP9; the disease is urinary bladder carcinoma.